Dhanvantari Medicine & Equipments Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 26-06-2024
- Paid Up Capital ₹ 1.37 M
as on 26-06-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.04 M
as on 26-06-2024
- Revenue 32.38%
(FY 2020)
- Profit 76.99%
(FY 2020)
- Ebitda 84.25%
(FY 2020)
- Net Worth 32.13%
(FY 2020)
- Total Assets 21.38%
(FY 2020)
About Dhanvantari Medicine & Equipments
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.37 M.
The company currently has active open charges totaling ₹4.04 M.
Mamta Pandey and Mamta Kumar serve as directors at the Company.
- CIN/LLPIN
U51507WB2005PTC104683
- Company No.
104683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2005
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dhanvantari Medicine & Equipments?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamta Pandey  | Director | 18-Sep-2021 | Current |
| Mamta Kumar | Director | 10-Aug-2005 | Current |
Financial Performance and Corporate Structure Insights of Dhanvantari Medicine & Equipments.
Dhanvantari Medicine & Equipments Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 32.38% increase. The company also saw a substantial improvement in profitability, with a 76.99% increase in profit. The company's net worth Soared by an impressive increase of 32.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhanvantari Medicine & Equipments?
In 2020, Dhanvantari Medicine & Equipments had a promoter holding of 75.78% and a public holding of 24.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inura Pharmaceutical Private Limited
Active
11 years 7 months Mamta Pandey and Mamta Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Nov 2021 | ₹0.50 M | Open |
Others Creation Date: 19 Oct 2016 | ₹3.54 M | Open |
How Many Employees Work at Dhanvantari Medicine & Equipments?
Dhanvantari Medicine & Equipments has a workforce of 20 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of May 02, 2011, Dhanvantari Medicine & Equipments has raised a total of ₹ 1.63 M, with the most recent deal valued at ₹ 1.01 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
